An important role for Cholecystokinin, a CLOCK target gene, in the development and treatment of manic-like behaviors

[1]  D. Kupfer,et al.  Advances in bipolar disorder: selected sessions from the 2011 International Conference on Bipolar Disorder , 2011, Annals of the New York Academy of Sciences.

[2]  J. Quevedo,et al.  Behavioral and neurochemical effects of sodium butyrate in an animal model of mania , 2011, Behavioural pharmacology.

[3]  L. Mahadevan,et al.  Dynamic acetylation of all lysine-4 trimethylated histone H3 is evolutionarily conserved and mediated by p300/CBP , 2011, Proceedings of the National Academy of Sciences.

[4]  A. Harvey.  Sleep and circadian functioning: critical mechanisms in the mood disorders? , 2011, Annual review of clinical psychology.

[5]  Michelle M Sidor,et al.  Specific Role of VTA Dopamine Neuronal Firing Rates and Morphology in the Reversal of Anxiety-Related, but not Depression-Related Behavior in the ClockΔ19 Mouse Model of Mania , 2011, Neuropsychopharmacology.

[6]  P. Thibault,et al.  H3 Lysine 4 Is Acetylated at Active Gene Promoters and Is Regulated by H3 Lysine 4 Methylation , 2011, PLoS genetics.

[7]  Paolo Sassone-Corsi,et al.  The histone methyltransferase MLL1 permits the oscillation of circadian gene expression , 2010, Nature Structural &Molecular Biology.

[8]  Laurent Coque,et al.  Knockdown of Clock in the Ventral Tegmental Area Through RNA Interference Results in a Mixed State of Mania and Depression-Like Behavior , 2010, Biological Psychiatry.

[9]  M. Schalling,et al.  CRY2 Is Associated with Rapid Cycling in Bipolar Disorder Patients , 2010, PloS one.

[10]  C. McClung,et al.  ΔFosB indirectly regulates Cck promoter activity , 2010, Brain Research.

[11]  S. Rotzinger,et al.  Behavioral effects of neuropeptides in rodent models of depression and anxiety , 2010, Peptides.

[12]  M. Gratacós,et al.  Differential Association of Circadian Genes with Mood Disorders: CRY1 and NPAS2 are Associated with Unipolar Major Depression and CLOCK and VIP with Bipolar Disorder , 2010, Neuropsychopharmacology.

[13]  M. Berk,et al.  Is Lithium in a Class of Its Own? A Brief Profile of Its Clinical Use , 2009, The Australian and New Zealand journal of psychiatry.

[14]  Matcheri Keshavan,et al.  Association study of 21 circadian genes with bipolar I disorder, schizoaffective disorder, and schizophrenia. , 2009, Bipolar disorders.

[15]  C. Nievergelt,et al.  Circadian polymorphisms associated with affective disorders , 2009, Journal of circadian rhythms.

[16]  J. Kleinman,et al.  Metabotropic Glutamate Receptor 2 and 3 Gene Expression in The Human Prefrontal Cortex and Mesencephalon in Schizophrenia , 2008, The International journal of neuroscience.

[17]  Diane B. Boivin,et al.  The role of circadian clock genes in mental disorders , 2007, Dialogues in clinical neuroscience.

[18]  Enrico Smeraldi,et al.  Actimetric evidence that CLOCK 3111 T/C SNP influences sleep and activity patterns in patients affected by bipolar depression , 2007, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[19]  C. McClung,et al.  Circadian genes, rhythms and the biology of mood disorders. , 2007, Pharmacology & therapeutics.

[20]  Kole T. Roybal,et al.  Mania-like behavior induced by disruption of CLOCK , 2007, Proceedings of the National Academy of Sciences.

[21]  Wen-Ning Zhao,et al.  CIPC is a mammalian circadian clock protein without invertebrate homologues , 2007, Nature Cell Biology.

[22]  Carol A. Tamminga,et al.  Human postmortem tissue: What quality markers matter? , 2006, Brain Research.

[23]  Paolo Sassone-Corsi,et al.  Circadian Regulator CLOCK Is a Histone Acetyltransferase , 2006, Cell.

[24]  C. Nievergelt,et al.  Suggestive evidence for association of the circadian genes PERIOD3 and ARNTL with bipolar disorder , 2006, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[25]  E. Nestler,et al.  Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action , 2006, Nature Neuroscience.

[26]  D. Kupfer,et al.  Association study of eight circadian genes with bipolar I disorder, schizoaffective disorder and schizophrenia , 2006, Genes, brain, and behavior.

[27]  Cyrus Martin,et al.  The diverse functions of histone lysine methylation , 2005, Nature Reviews Molecular Cell Biology.

[28]  J. Takahashi,et al.  Regulation of dopaminergic transmission and cocaine reward by the Clock gene. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[29]  E. Nestler,et al.  Histone Modifications at Gene Promoter Regions in Rat Hippocampus after Acute and Chronic Electroconvulsive Seizures , 2004, The Journal of Neuroscience.

[30]  J. Burgunder,et al.  Circadian patterns of neurotransmitter related gene expression in motor regions of the rat brain , 2004, Neuroscience Letters.

[31]  A. Serretti,et al.  Genetic dissection of psychopathological symptoms: Insomnia in mood disorders and CLOCK gene polymorphism , 2003 .

[32]  V. Wiegant,et al.  Regulation of cholecystokinin release from central nerve terminals , 2001, Peptides.

[33]  T. Hansen.  Cholecystokinin gene transcription: promoter elements, transcription factors and signaling pathways , 2001, Peptides.

[34]  F. Vaccarino,et al.  Cholecystokinergic Innervation of Nucleus Accumbens Subregions , 1998, Peptides.

[35]  D. P. King,et al.  The mouse Clock mutation behaves as an antimorph and maps within the W19H deletion, distal of Kit. , 1997, Genetics.

[36]  J. Bellach,et al.  Circadian rhythms of dopamine and cholecystokinin in nucleus accumbens and striatum of rats--influence on dopaminergic stimulation. , 1995, Chronobiology international.

[37]  B. Roques,et al.  The CCKB receptor antagonist, L-365,260, elicits antidepressant-type effects in the forced-swim test in mice. , 1994, European journal of pharmacology.

[38]  D. P. King,et al.  Mutagenesis and mapping of a mouse gene, Clock, essential for circadian behavior. , 1994, Science.

[39]  S. Kito,et al.  Cholecystokinin increases intracellular Ca2+ concentration in cultured striatal neurons , 1991, Neuropeptides.

[40]  B. Costall,et al.  Development of a class of selective cholecystokinin type B receptor antagonists having potent anxiolytic activity. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[41]  Rex Y. Wang,et al.  In vivo release of dopamine in the nucleus accumbens of the rat: modulation by cholecystokinin , 1984, Brain Research.

[42]  T. Hökfelt,et al.  Evidence for coexistence of dopamine and CCK in meso-limbic neurones , 1980, Nature.

[43]  Ethan D Buhr,et al.  Molecular components of the Mammalian circadian clock. , 2013, Handbook of experimental pharmacology.

[44]  Nicolas Cermakian,et al.  Circadian rhythms and clock genes in psychotic disorders. , 2010, The Israel journal of psychiatry and related sciences.

[45]  J. Aubry,et al.  Lithium: Updated Human Knowledge Using an Evidence-Based Approach , 2009, CNS drugs.

[46]  V. J. Polidora.  Behavioral Effects of , 1967 .